Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Longitudinal Volumetric Analysis of FLAIR Hyperintensity Following Radiation Therapy (RT) in Patients with Low-grade Glioma (LGG)

              Author:Sutherland, Isabella   Ulano, Adam   Thomas, Alissa   

              Session Name:P4: Neuro-oncology: Frontiers in Neuro-oncology  

              Topic:Neuro-oncology  

              Program Number:P4.019  

              Author Institution:University of Vermont Larner College of Medicine, Burlington, VT  University of Vermont Medical Center, Burlington, VT  

              Optimizing a Patient’s Oral CD-LD Dosing Regimen Is Critical for Improving Efficacy in Parkinson’s Disease

              Author:Hauser, Robert   Moore, Henry   Banisadr, Ghazal   D'Souza, Richard   

              Session Name:P4: Movement Disorders: Parkinson's Disease Clinical Aspects 1  

              Topic:Movement Disorders  

              Program Number:P4.019  

              Author Institution:Movement Disorders Center, Tampa, FL  University of Miami - Miller School of Medicine, Miami, FL  Amneal Pharmaceuticals, Evanston, IL  Amneal Pharmaceuticals, Morristown, NJ  

              Uncontrolled Myasthenia Gravis Can Contribute to Additional Stress Burden and Adverse Mental Health Experiences

              Author:Gwathmey, Kelly   Rodriguez, Rachelle   Choudhry, Zia   Jackson, Louis   Peters, Wesley   Geonnotti, Gabrielle   Ramchandren, Sindhu   Ait-Tihyaty, Maria   Goyal, Neelam   

              Session Name:P4: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P4.019  

              Author Institution:VCU Neuroscience, Orthopedic, and Wellness, Henrico, VA  The Janssen Pharmaceutical Companies of Johnson & Johnson, Raritan, NJ  The Janssen Pharmaceutical Companies of Johnson & Johnson , Horsham, PA  The Janssen Pharmaceutical Companies of Johnson & Johnson, Titusville, NJ  Corevitas, Waltham, MA  The Janssen Pharmaceutical Companies of Johnson & Johnson, Knoxville, TN  Stanford University, Palo Alto, CA  

              Subacute Inflammatory Demyelinating Polyneuropathy (SIDP) Secondary to Tumor Necrosis Factor (TNF)-Alpha Inhibitor (Adalimumab) for the Treatment of Rheumatoid Arthritis: A Case Report

              Author:Bartnik, Natalie   Grady, Mark   Beattie, Sean   Maali, Laith   

              Session Name:P4: Autoimmune Neurology: Peripheral Autoimmunity  

              Topic:Autoimmune Neurology  

              Program Number:P4.019  

              Author Institution:University of Kansas Medical Center, Kansas City, KS  Children’s Mercy Hospital, Kansas City, MO